What the OpioidHALT pilot study tells us
The results of the OpioidHALT pilot study show that 90% of patients reduced their opioid doses by at least 50% compared with 17% in the control group and […]
The results of the OpioidHALT pilot study show that 90% of patients reduced their opioid doses by at least 50% compared with 17% in the control group and […]
The OpioidHALT intervention is tailored to the needs of individual patients and evaluated for safety by a pain specialist. Shared decision-making, with the patient, is an important feature […]
FIP’s Early Career in Pharmaceutical Practice Recognition Award recognises an outstanding early career pharmacist who has made significant contributions to the field at a national level and is […]
Opioid doses can be successfully reduced by a pharmacy-led intervention, according to a randomised study led by Dr Shania Liu and Dr Jonathan Penm at the University of […]
Paul Rutter is Professor of Pharmacy Practice at Portsmouth University and the author of a best-selling textbook on symptoms, diagnosis and treatment in community pharmacy. His new book […]
The introduction of clinical reasoning and diagnosis as routine elements of community pharmacy practice will present a number of challenges and could pave the way for closer working […]
Clinical reasoning skills are essential for effective consultations that lead to likely diagnoses and appropriate treatment or referral, argues Paul Rutter, Professor of Pharmacy Practice at Portsmouth University […]
Paul Rutter is Professor of Pharmacy Practice at Portsmouth University and the author of a best-selling textbook on symptoms, diagnosis and treatment in community pharmacy. His new book […]
Kieron Power is Principal Pharmacist for Thrombosis and Anticoagulation in Swansea Bay University Health Board in South Wales. He has played a leading role in the development of […]
A number of features have contributed to the success of the pharmacy-led outpatient PE pathway including a close working relationship with the doctors, the systematic delivery of seven-day […]
Evaluation of the new outpatient pulmonary embolism pathway showed that about 30% of patients could be managed safely and effectively via this route. Kieron Power, Principal Pharmacist for […]
The pulmonary embolism pathway has been designed to ensure acute risk assessment and appropriate follow up for all pulmonary embolism patients whether treated as inpatients or outpatients, according […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.